BRIEF published on 03/20/2026 at 13:05, 1 month 22 days ago ReproNovo Appoints Mark Altmeyer as Chairman of the Board Biopharmaceutical Fertility Leadership ReproNovo Mark Altmeyer
BRIEF published on 03/20/2026 at 13:05, 1 month 22 days ago ReproNovo nomme Mark Altmeyer président du conseil d'administration Biopharmaceutique Direction ReproNovo Mark Altmeyer Fécondité
PRESS RELEASE published on 03/20/2026 at 13:00, 1 month 22 days ago REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD ReproNovo appoints Mark Altmeyer as Chairman of the Board. Altmeyer brings 35+ years of biopharma leadership experience across multiple therapeutic areas Chairman Fertility Biopharma ReproNovo Mark Altmeyer
BRIEF published on 09/30/2025 at 07:05, 7 months 11 days ago ReproNovo Gains Approval for RPN-001 Clinical Trial in China Clinical Trial China Approval ReproNovo Reproductive Medicine RPN-001
BRIEF published on 09/30/2025 at 07:05, 7 months 11 days ago ReproNovo obtient l'approbation pour l'essai clinique RPN-001 en Chine Essai Clinique ReproNovo RPN-001 Approbation De La Chine Médecine De La Reproduction
PRESS RELEASE published on 09/30/2025 at 07:00, 7 months 11 days ago ReproNovo Announces Clinical Trial Approval Notice for RPN-001 in China ReproNovo receives approval for RPN-001 Phase 1 trial in China from NMPA, a key step in global development for male infertility treatment. Company expanding clinical programs in the U.S. and China China Male Infertility Clinical Trial ReproNovo RPN-001
BRIEF published on 07/01/2025 at 07:05, 10 months 10 days ago ReproNovo Initiates Phase 2 Trial for Male Infertility Drug in the U.S. Male Infertility Phase 2 Trial ReproNovo RPN-001 Low Testosterone
BRIEF published on 07/01/2025 at 07:05, 10 months 10 days ago ReproNovo lance un essai de phase 2 pour un médicament contre l'infertilité masculine aux États-Unis Essai De Phase 2 ReproNovo RPN-001 Infertilité Masculine Faible Taux De Testostérone
PRESS RELEASE published on 07/01/2025 at 07:00, 10 months 10 days ago REPRONOVO ANNOUNCES FIRST PARTICIPANT INCLUDED IN U.S. PHASE 2 TRIAL OF RPN-001 FOR MALE INFERTILITY ReproNovo announces first participant in U.S. Phase 2 trial of RPN-001 for male infertility, aiming to develop oral therapy for low testosterone men with impaired semen quality Male Infertility Phase 2 Trial ReproNovo RPN-001 Aromatase Inhibitor
BRIEF published on 05/21/2025 at 07:05, 11 months 21 days ago ReproNovo Secures $65 Million for Phase 2 Trials in Reproductive Health Innovation Clinical Trials Series A Financing Reproductive Health ReproNovo
Published on 05/11/2026 at 23:00, 38 minutes ago Revolve to Present at the 16th Annual LD Micro Invitational on May 18, 2026
Published on 05/11/2026 at 19:55, 3 hours 43 minutes ago Lithium South Announces Pay Out of Common Shares and Closing of Plan of Arrangement
Published on 05/11/2026 at 19:30, 4 hours 8 minutes ago Taranis Adjusts Thor Exploration Program Due to Current Political and Regulatory Conditions in British Columbia
Published on 05/11/2026 at 14:30, 9 hours 8 minutes ago Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
Published on 05/11/2026 at 14:00, 9 hours 38 minutes ago Unusual Machines Accelerates Domestic Battery Manufacturing by Signing a Merger Agreement to Acquire Upgrade Energy
Published on 05/11/2026 at 22:05, 1 hour 33 minutes ago Abivax annonce les résultats de son Assemblée Générale du 11 mai 2026
Published on 05/11/2026 at 22:05, 1 hour 33 minutes ago Abivax Announces Results of its May 11, 2026 Annual General Meeting
Published on 05/11/2026 at 21:16, 2 hours 22 minutes ago Original-Research: Intershop Communications (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 05/11/2026 at 20:42, 2 hours 56 minutes ago Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 20:40, 2 hours 58 minutes ago EQS-Adhoc: Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 19:02, 4 hours 36 minutes ago 260511 BENETEAU Transactions sur actions propres
Published on 05/11/2026 at 18:18, 5 hours 20 minutes ago Reporting on share buyback transactions carried out between May 4 and May 5, 2026
Published on 05/11/2026 at 18:18, 5 hours 20 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026
Published on 05/11/2026 at 18:14, 5 hours 24 minutes ago Nombre total d'actions et droits de vote - avril 2026
Published on 05/11/2026 at 18:14, 5 hours 24 minutes ago Number of shares and voting rights - April 2026 (In French only)
